The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease

Authors: Neale S.D.1; Schulze E.1; Smith R.1, 2; Athanasou N.A.1, 2

Source: QJM: An International Journal of Medicine, Volume 95, Number 4, April 2002 , pp. 233-240(8)

Publisher: Oxford University Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: Osteoclasts are multinucleated cells (MNCs) that form from circulating mononuclear precursors in the presence of the receptor activator of nuclear factor kappaB-ligand (RANKL) and macrophage-colony stimulating factor (M-CSF).

Aim: To determine whether cytokines and growth factors influence RANKL/M-CSF induced osteoclastogenesis and bone resorption in Paget's disease.

Design: Prospective case-control study.

Methods: Serum levels of M-CSF, interleukin (IL)-1beta, IL-6 and tumour necrosis factor-alpha (TNFalpha) were measured in 13 Paget's disease patients and 8 normal controls. The effect of serum from Paget's patients on osteoclast formation was also assessed.

Results: Serum levels of IL-1beta, IL-6 and TNFalpha were low or undetectable in Paget's disease patients and normal controls. Levels of M-CSF were significantly increased in Paget's patients who were not currently under treatment. In Paget's patients under treatment, serum M-CSF levels were not significantly different from normal controls. The addition of serum from untreated Paget's patients dose-dependently increased RANKL-induced osteoclast formation and lacunar resorption in normal monocyte cultures; elevated IL-6 levels were found in the supernatant and the addition of a specific antibody to human IL-6 blocked the increase in osteoclast formation and resorption. Serum from untreated Paget's patients also induced osteoclast formation in the absence of exogenous M-CSF; an antibody specific to human M-CSF abolished this effect.

Discussion: Both M-CSF and IL-6 play a major role in osteoclast formation and bone resorption in Paget's disease and measurement of serum M-CSF may provide a useful indicator of disease activity.

Document Type: Original article

Affiliations: 1: From the Nuffield Department of Orthopaedic Surgery, University of Oxford, and 2: Department of Pathology, Nuffield Orthopaedic Centre, Oxford, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.03 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A